Fund profile

ACME Capital

San Francisco, United States

Leading

About

ACME Capital, founded in 2018 and headquartered in San Francisco, is an early-stage venture capital firm specializing in transformative technologies and business model innovations. They invest in deep tech, hardware, disruptive consumer products, enterprise solutions, fintech, health, and web3 sectors. Notable portfolio companies include IonQ, Braintrust, Cue Health, Astra, Uhnder, and Forte, which exemplify ACME’s commitment to pioneering advancements and societal benefits. ACME's strategy emphasizes partnering with founders from ideation through to IPO, offering not just capital but also strategic support and valuable industry connections. They favor investments in companies demonstrating significant market traction and a clear path to scalability. Their recent Fund IV and adjacent Opportunity Fund raised over $300 million, underscoring their robust position in the venture capital landscape. ACME is also dedicated to diversity and inclusion, with a substantial portion of their investments and team members representing historically underrepresented groups. Key team members include Co-founders Hany Nada and Scott Stanford, who bring extensive experience in venture capital and entrepreneurship, enhancing ACME’s ability to guide startups toward successful exits.

Details

Highlights

$1.4M

Historical average check

$100M

Historical max check

January 2025

Last investment date

198

Investments

Biotech

Hardware. Robotics & IoT

AI & Deep Tech

Healthtech & Wellness

Software & Apps

Consumer Goods & Electronics

Web 3.0

Pharma

Transportation & Mobility

Data & Analytics

Natural Resources

Other

Funds that also invest in AI & Deep Tech